Dopa-Responsive Dystonia Is Caused by Particular Impairment of Nigrostriatal Dopamine Neurons Different from Those Involved in Parkinson Disease: Evidence Observed in Studies on Segawa Disease

Abstract

From the characteristics of its clinical features, Segawa disease is considered to be caused by deficiency of the tyrosine hydroxylase (TH) of the nigrostriatal dopamine neurons, which have high TH activities in the terminal but not in the perikaryon. This hypothesis was confirmed by two autopsied cases. However, these cases were younger than 40 years and left a question as to whether these abnormalities turned to those of Parkinson disease in older ages. An autopsy of a 90-year-old woman with Segawa disease confirmed the hypothesis that Segawa disease has a completely different pathophysiology and pathology than Parkinson disease.

Keywords

Segawa disease - Parkinson disease - nigrostriatal dopamine neuron

• References

• 1 Segawa M, Nomura Y. Hereditary progressive dystonia with marked diurnal fluctuation. Pathophysiological importance of the age of onset. Adv Neurol 1993; 60: 568-576
• 2 Kreiss DS, Anderson LA, Walters JR. Apomorphine and dopamine D(1) receptor agonists increase the firing rates of subthalamic nucleus neurons. Neuroscience 1996; 72: 863-876
• 3 Kreiss DS, Mastropietro CW, Rawji SS, Walters JR. The response of subthalamic nucleus neurons to dopamine receptor stimulation in a rodent model of Parkinson's disease. J Neurosci 1997; 17: 6807-6819
• 4 McGeer EG, McGeer PL. Some characteristics of brain tyrosine hydroxylase. In: Mandel J, , ed. New Concepts in Neurotransmitter Regulation. New York, London: Plenum; 1973: 53-68
• 5 Gibb WRG. Selective pathology, disease pathogenesis and function in the basal ganglia. In: Kimura J, Shibasaki H, , eds. Recent advances in clinical neurophysiology. Amsterdam: Elsevier; 1996: 1009-1015
• 6 Segawa M. Development of the nigrostriatal dopamine neuron and the pathways in the basal ganglia. Brain Dev 2000; 22 (Suppl. 01) S1-S4
• 7 Segawa M, Tanaka R, Nomura Y, Fukuda H. Hikosaka O. Saccadic eyemovements in basal ganglia disorders. In: Kimura J, Shibasaki H, , eds. Recent Advances in Clinical Neurophysiology. Amsterdam, The Netherlands: Elsevier; 1996: 170-176
• 8 Hornykiewicz O. Striatal dopamine in dopa-responsive dystonia: comparison with idiopathic Parkinson's disease and other dopamine-dependent disorders. In: Segawa M, Nomura Y, , eds. Age-Related Dopamine-Dependent Disorders. Monogr Neural Sci. Vol.14. Basel: Karger; 1995: 101-108
• 9 Rajput AH, Gibb WR, Zhong XH , et al. Dopa-responsive dystonia: pathological and biochemical observations in a case. Ann Neurol 1994; 35: 396-402
• 10 Narabasyshi H, Yokochi M, Iizuka R, Nagatsu T. Juvenile Parkinsonism. In: Vinken PJ, Bruyu GW, Klowans HI, , eds. Handbook of clinical neurology, vol. 5(49). Extrapyramidal disorders. Amsterdam, The Netherlands: Elsevier Science Publishers B.V; 1986: 153-165
• 11 Segawa M, Nomura Y, Nishiyama N. Autosomal dominant guanosine triphosphate cyclohydrolase I deficiency (Segawa disease). Ann Neurol 2003; 54 (Suppl. 06) S32-S45
• 12 Ito M, Takashima S. Neuropathology and immunohistochemistry of brains with Rett syndrome. No to Hattatsu [in Japanese] (Tokyo) 2002; 34: 211-216
• 13 Segawa M. Discussant—pathophysiologies of Rett syndrome. Brain Dev 2001; 23 (Suppl. 01) S218-S223